Abstract

Older adults have relatively weak immune and antioxidant systems and thus, are more vulnerable to viral infections especially respiratory tract infections as compared to younger adults. Recent reports of high mortality rate due to the Coronavirus disease 2019 (COVID-19) in the elderly population are suggestive that perhaps a compromised antioxidant status might be contributing to increased virulence in elderly people. Since vitamin E insufficiency is common in old age, it is conceivable that low vitamin E status could be among the factors causing high mortality in elderly people suffering from influenza and COVID-19 infections. Recent studies have shown an immune-boosting role of supplemental vitamin E along with other antioxidants against respiratory tract viral infections. Therefore, the objective of this review is to examine and discuss the data pertaining to the effects of vitamin E on boosting the immune response against respiratory tract viral infections such as influenza and COVID-19 in elderly individuals.

Keywords: Vitamin E supplementation, elderly population, antioxidant status, immune system, respiratory tract infections, influenza,COVID-19.

INTRODUCTION

Vitamin E was originally discovered by Herbert McLean Evans and Katharine Scott Bishop as an essential dietary nutrient required for normal animal fertility and reproduction [1]. The main dietary sources of vitamin E include nuts, vegetable seeds and their oils and grains [2].

Table 1 shows the major dietary sources and the average amount of vitamin E per 100 grams of food [3]. Potential health benefits of dietary vitamin E intake in humans are mostly related to the prevention of certain types of cancer, heart disease and other chronic degenerative disorders [4].

Vitamin E is one of the most potent fat-soluble antioxidants located predominantly in the human

Table 1: Major dietary sources and average amount of vitamin E per 100 grams of food [3].

cellular membranes, especially in the erythrocyte and muscle membranes. Vitamin E due to its antioxidant action prevents oxidative stress-induced cellular lipid peroxidation and proteolysis. Normal plasma vitamin E (ɑ-tocopherol) levels in healthy human adults may vary depending upon the consumption of a diet rich or poor in vitamin E and generally ranges between 5 μg/ ml to 15 μg/ml [5, 6]. However, the prevalence of human vitamin E deficiency is low, and in elderly subjects, it is often associated with dietary deficiency and chronic gastrointestinal tract fat malabsorption syndromes [7, 8]. Due to this reason, deficiency of this anti-oxidant vitamin is believed to be more than the younger population. Since the immune system is compromised in elderly people, they become more vulnerable to various viral infections including Coronavirus disease 2019 (COVID-19) infection. The objective of this review is to examine and discuss various lines of evidence regarding the effects of vitamin E on boosting the immune response against respiratory tract viral infections such as influenza and COVID-19 in elderly people.

METHODS

Research Design and Methods: A systematic literature review was conducted to examine the data pertaining to the effects of vitamin E on boosting the immune response against respiratory tract viral infections such as influenza and COVID-19 in apparently healthy elderly humans.

Search Strategy and Selection Criteria: In this review, the authors explored in detail the scientific works from March 1989 till August 2021 related to the effects of vitamin E on boosting the immune response against respiratory tract viral infections in elderly individuals. The search strategy adopted was an article title/ keywords/abstract-based search using key terms such as ‘vitamin E’, ‘tocopherol’, ‘elderly people’, ‘antioxidant status’, ‘immune system’, ‘respiratory tract infections, and ‘COVID-19’. The literature searches for locating, selecting, extracting, and analyzing the published data were performed using PubMed, Web of Science and Google Scholar. The selected articles and some of their linked references were also reviewed to obtain relevant information. However, the focus was on the effect of vitamin E on the immune system in elderly people and the mechanism of action in case of any protection against respiratory tracts viral infections such as influenza and COVID-19. The pertinent information including authors, institute, study setting, duration, sample size, target population, age group, objectives and dosage used were extracted from a total of 345 retrieved articles.

Vitamin E and Immune System in Elderly People Effect of Vitamin E on Immune System Normal aging process in otherwise healthy elderly individuals is associated with a progressive decline in both cell- mediated and humoral immunity. This deterioration in the immune status with increasing age is due to decreased synthesis and release of CD4 +ve and CD8 +ve T lymphocytes, natural antibodies and natural killer (NK) cells, increased destruction of circulating neutrophils by apoptosis, increased production of pro-inflammatory cytokines ( e.g. Interleukin-1β, Interleukin-6, Interleukin-8 and Tumor necrosis factor-alpha) with simultaneous decreased production of anti-inflammatory cytokines (e.g. Interleukin-2 and Interferon-gamma), enhanced production of autoantibodies, reduced immune responses to vaccination and impairment inability to generate immune responses against new/ novel antigens [9-11].

Moreover, some of the earlier studies have suggested that healthy elderly individuals have a relatively compromised antioxidant status [12, 13]. Thus, apparently healthy elderly humans are more predisposed than younger adults to infections, chronic inflammatory diseases, and cancers [14]. Antioxidant vitamins aresuggested to modulate and boost up the human immune system [15, 16]. Multiple double-blinded, case-control and placebo-control clinical trials have suggested that supplementation with both natural and synthetic vitamin E given for 1-6 months to apparently healthy elderly human subjects significantly improved their natural and acquired immunity [17-19]. The suggested major immunomodulatory effects of dietary vitamin E in immune cells are depicted in Fig. (1) [17-19].

Vitamin E Protection Against Respiratory Tract Infections. Acute respiratory tract infections are a major cause of morbidity and mortality worldwide. The enhanced respiratory oxidative stress due to viral infections such as influenza has been shown to increase the severity of lung inflammation and altered immune responses, especially in old people and immunosuppressed patients [20].

Some of the antioxidants including vitamin E and its various forms had been previously proposed to play a significant role in protecting lung cells against viral and bacterial infections which often lead to increased intrapulmonary oxidative burden [21, 22].

Some of the earlier clinical trials in the elderly have demonstrated beneficial effects of vitamin E in protecting against acute respiratory infections [23, 24].

An earlier experimental animal study conducted on white male albino mice indicated that treatment with alpha-tocopherol significantly reduced the mortality rate and enhanced the mean survival time of these albino mice inoculated with influenza virus [25]. The results of a previous randomized control trial showed that supplementation with 200 I U of vitamin E per day had a protective effect on upper respiratory tract infections, especially the common cold in elderly people [26]. The protective effect of vitamin E against viral infections is further supported by in vitro experiments in a mouse model in an earlier study by Beck et al. showing that the host nutritional status in terms of antioxidants such as vitamin E and selenium is critical not only for virulence

Fig. (1): Immune modulatory mechanisms of vitamin E in human cells (17-19).

but might also be influencing the genetic make-up of the virus [27].

Vitamin E and COVID-19

Novel COVID-19 is an acute respiratory viral infection that was initially reported to emerge in December 2019 from Wuhan, China and then within a few months became a worldwide pandemic [28]. Coronavirus infection has been proposed to dysregulate the human immune system by causing pro-inflammatory cytokines (Interleukin-2, I Interleukin-6, Interleukin-7, Tumor necrosis factor-ɑ and Granulocyte-colony stimulating factor) hyper release syndrome, reduction in T and B lymphocytes, decreased activity of NK cells and hyperactivation of cytotoxic T cells [29, 30].

Some of the recent studies have illustrated that the severity of COVID-19 is far more in elderly individuals as compared to children and young adults. Poor nutritional status of elderly people (in terms of low levels of essential nutrients and vitamins) in COVID-19 could be contributing to increased virulence and pathology/ mortality in these patients. There is a “cytokine storm” in elderly COVID-19 patients and perhaps due to low levels of some of the vitamins (such as vitamins D, A, C, E), these elderly patients are unable to suppress these pro-inflammatory cytokines [31]. Moreover, some human studies have pointed out the potential role of some of the vitamins in the management of COVID-19 patients [32].

It has been suggested that oxidative stress due to excessive production of reactive oxygen species (ROS) might lead to severe local or systemic tissue damage in COVID-19 patients [33]. Some most recent studies have suggested the possible use of dietary and supplemental antioxidant vitamins in the treatment of COVID-19 [34]. Moreover, treatment with some of the antioxidants could play a significant role in the management of excessive inflammation and “cytokine storm” in the elderly COVID-19 patients [35].

Vitamin E Deficiency and Viral Infections

Vitamin E deficiency had been suggested to increase the virulence and the extent of tissue injury by respiratory viruses in experimental animal studies [36]. Earlier animal studies had suggested the potential use of vitamin E in the treatment of influenza virus infections. It was demonstrated that mice experimentally infected with the influenza virus had developed significantly reduced levels of endogenous vitamin E, and supplementation with vitamin E attenuated the free radicals induced by the virus [37]. An association between decreased vitamin E and D status and infection of bovine coronavirus has been suggested [37].

All these reports support the therapeutic potential of vitamin E against viral infections. However, no clinical trials have been carried out to evaluate the therapeutic potential of vitamin E alone in COVID-19. Some of the recent studies suggest that oxidative stress should bereduced in frail people suffering from COVID-19 infection by increasing their antioxidant defense system [38].

A recent randomized controlled trial is underway to examine the impact of vitamins A, B, C, D and E supplementation on the improvement and mortality rate of COVID-19 patients [39]. The results are likely to provide reasonable evidence regarding the outcomes of this intervention. Moreover, a recent study suggested an immune-boosting role of some of the dietary antioxidants including selenium, vitamin C and vitamin E as well as their specific effect in COVID-19 patients [40].

Older adults (> 65 years) have relatively compromised immune responses as well as antioxidant defense mechanisms, which increases the risk of both infections and chronic inflammatory diseases in them as compared with younger adults [38]. Recent reports of high mortality rates among elderly COVID-19 patients are suggestive that perhaps a compromised antioxidant status might be contributing to severe pathology and increased virulence in elderly people [41]. Since vitamin E insufficiency is most likely to occur in old age, it is conceivable that low vitamin E status and a relatively weak immune system could be among the factors causing high mortality in elderly people suffering from influenza and COVID-19 infections [42]. Some of the recent clinical trials have indicated that supplemental antioxidant vitamins including vitamin E could be beneficial in reducing the morbidity and mortality of patients infected with respiratory viral infections such as influenza and COVID-19 [43]. However, large clinical trials with larger numbers of subjects are required to unravel this phenomenon.

Immune-boosting in Elderly by Vitamin E

In a recent chapter in a book on vitamin E in Health and Disease, the role of vitamin E in enhancing immunity in elderly people has been highlighted [44]. Vitamin E was found to increase resistance against viral infections and stimulate the immune response against distinctive antigens. In an interventional study, supplementation with 200 mg of vitamin E per day boosted the immune response in elderly subjects including enhanced T cell proliferation. However, dietary intake of vitamin E is the best approach to enhance immunity in the elderly, especially in immuno-compromised persons [45]. Supplementation with vitamin E was found to reverse the age-associated decline in immune responses [45].

Vitamin E Rich Foods

Although Table 1 lists various vitamin E-rich seed oils and nuts, yet in a balanced diet, different food items need to be consumed to meet the essential nutrient requirements. Some of the other dietary sources of vitamin E include broccoli, spinach, kiwi fruit, fish and egg yolk [2, 46]. It is suggested that in elderly persons vitamin E-rich diet should preferably be used to meet their Recommended Dietary Allowance (RDA) of 15 mg/ day for this vitamin.

Recommendations/Way Forward

1. Primary care has a special focus on the elderly population. An adequate anti-oxidant status of elderly people is essential for the prevention of disease in them. Vitamin E along with other anti- oxidants has great potential. However, the health benefits of vitamin E supplementation in respiratory viral infections and COVID-19 could be more evident through well-planned, large-scale intervention studies in humans especially those having vitamin E deficiency/insufficiency.

2. The relationship of vitamin E insufficiency with severity in the pathology of COVID-19 in elderly people needs further investigation.

CONCLUSION

Vitamin E supplementation is likely to be more beneficial in the elderly population especially those with less than normal levels or compromised antioxidants status. Further research studies are needed to investigate any protective and/or curative role of vitamin E against COVID-19.

ABBREVIATIONS

Natural killer (NK) cells, Interleukin-2 (IL2), Interleukin-4 (IL4), Interferon-gamma (IFN-γ), Prostaglandin E2 (PGE2), Cyclooxygenase 2 (COX 2) activity.

FUNDING

Our study involved no funding.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

ACKNOWLEDGEMENTS

Declared none.

REFERENCES

1. Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science 1922; 56(1458): 650-51.

2. Rizvi S, Raza ST, Ahmed F, Ahmad A, Abbas S, Mahdi F. The role of vitamin E in human health and some diseases. Sult Qaboos Univ Med J 2014; 14(2): E157-E165.

3. Shahidi F, de Camargo AC. Tocopherols and tocotrienols in common and emerging dietary sources: Occurrence, applications, and health benefits. Int J Mol Sci 2016; 17(10): 1745.

4. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, et al. Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Am J Clin Nutr 2018; 108(5): 1069-91.

5. Meboobali N, Iqbal MP. A simple micro method for determination of plasma levels of alpha tocopherol (Vitamin E) in Pakistani normal adults. Pak J Pharm Sci 2008; 21(4): 361-5.

6. McBurney MI, Yu EA, Ciappio ED, Bird JK, Eggersdorfer M, Mehta S. Suboptimal serum ɑ-tocopherol concentrations observed among younger adults and those depending exclusively upon food sources. PloS One 2015; 10(8): e0135510.

7. Jilani T, Iqbal MP. Vitamin E deficiency in South Asian population and the therapeutic use of alpha-tocopherol (Vitamin E) for correction of anemia. Pak J Med Sci 2018; 34(6): 1571-6.

8. Traber MG. Vitamin E inadequacy in humans: causes and consequences. Adv Nutr 2014; 5(5): 503-14.

9. Fuentes E, Fuentes M, Alarcon M, Palomo I. Immune system dysfunction in the elderly. Ann. Acad Bras Cienc 2017; 89(1): 285- 99.

10. Fagnoni FF, Vescovini R, Passeri G, Bolonga G, Pedrazzoni M, Lavagetto G, et al. Shortage of circulating naïve CD8 (+) T cells provides new insights on immunodeficiency in aging. Blood 2000; 95(9): 2860-8.

11. Fortin CF, Larbi A, Dupuis G, Lesur O, Fulop Jr T. GM-CSF activates Jak-STAT pathway to rescue polymorphonuclear neutrophils from spontaneous apoptosis in young but not elderly individuals. Biogereontology 2007; 8(2): 173-87.

12. Dato S, De Rango F, Crocco P, Passarino G, Rose G. Antioxidants and quality of aging: Further evidences for a major role of TXNRD1 gene variability on physical performance at old age. Oxid Med Cell Longev 2015; 2015: 926067.

13. Campbell D, Bunker VW, Thomas AJ, Clayton BE. Selenium and vitamin E status of healthy and institutionalized elderly subjects: analysis of plasma, erythrocytes, and platelets. Br J Nutr 1989; 62(1): 221-7.

14. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM. Effect of Aspirin on all-cause mortality in the healthy elderly. N Engl J Med 2018; 379(16): 1519-28.

15. Lee GY, Han SN. The role of vitamin E in immunity. Nutrients 2018;

10(11): 1211.

16. Carr AC, Maggni S. Vitamin C and immune function. Nutrients

2017; 9(11): 1211.

17. Fuente M De la, Hernanz A, Guayerbas N, Victor VM, Arnalich F. Vitamin E ingestion improves several immune functions in elderly men and women. Free Rad Res 2008; 42(3): 272-80.

18. Wu D, Han SN, Meydani M, Meydani SN. Effect of concomitant consumption of fish oil and vitamin E on T cell mediated function in the elderly: a randomized double-blind trial. J Am Coll Nutr 2006; 25(4): 300-06.

19. Wu D, Mura C, Beharka AA, Han SN, Paulson KE, Hwag D, et al. Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol 1998; 275: C661-C668.

20. Rosano A, Bella A, Gesualdo F, Acampora A, Pezzotti P, Marchetti S, et al. Investigating the impact of influenza on excess mortality in all ages in Italy during recent seasons (2013/14-2016/17 seasons). Int J Infect Dis 2019; 88: 127-34.

21. Alvarado A, Arce I. Antioxidants in respiratory diseases. Basic science research and therapeutic alternatives. Clin Res Trials 2016; 3(1): 1-11.

22. Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life 2019; 71(4): 487- 94.

23. Hemila H. Vitamin E administration may decrease the incidence of

pneumonia in elderly males. Clin Interv Aging 2016; 11: 1379-85.

24. Meydani SN, Han SN, Wu D. Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev 2005; 205: 269-84.

25. Galab ov AS, Mileva M, Simeonova L, Gegova G. Combination activity of neuraminidase inhibitor oseltamivir and ɑ-tocopherol in influenza virus A (h4N2) infection in mice. Antivir Chem Chemother 2015; 24(3-4): 83-91.

26. Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004; 292(7): 828-36.

27. Beck MA, Handy J, Levander OA. Host nutritional status: the neglected virulence factor. Trends Microbiol 2004; 12(9): 417-23.